Gastroprotective effect of ranitidine bismuth citrate is associated with increased mucus bismuth concentration in rats

Gut

Volumn 39, Issue 2, 1996, Pages 164-171

  Tanaka, S ^a,b,c   Guth, P H ^a,b,c   Paulsen, G ^d   Kaunitz, J D ^a,b,c,d  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gastric mucus; Intracellular pH; Mucosal blood flow; Proton diffusion; Ranitidine bismuth citrate; Stomach

Indexed keywords

INDOMETACIN; RANITIDINE BISMUTH CITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STOMACH FUNCTION; STOMACH INJURY; STOMACH MUCOSA BLOOD FLOW; STOMACH MUCUS; STOMACH PH; STOMACH PROTECTION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029842339     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.2.164     Document Type: Article

References (55)

1. Konturek SJ, Kwiecien N, Obtulowicz W, Hebzda Z, Oleksy J. Effects of colloidal bismuth subcitrate on aspirin-induced gastric microbleeding, DNA loss, and prostaglandin formation in humans. Scand J Gastroenterol 1988; 23: 861-6.
2. Goldenberg MM, Honkomp LJ, Burrous SE, Castellon AW. Protective effect of Pepto-Bismol liquid on the gastric mucosa of rats. Gastroenterology 1975; 69: 636-40.
3. Slomiany BL, Nishikawa H, Bilski J, Slomiany A. Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro. Am J Gastroenterol 1990; 85: 390-3.
4. Tay HP, Chaparala RC, Harmon JW, Huesken J, Saini N, Hakki FZ, et al. Bismuth subsalicylate reduces peptic injury of the oesophagus in rabbits. Gut 1990; 31: 11-6.
5. Shorrock CJ, Crampton JR, Gibbons LC, Rees WDW. Effect of bismuth subcitrate on amphibian gastroduodenal bicarbonate secretion. Gut 1989; 30: 917-21.
6. Ehsanullah R, Page M, Tildesley G, Wood J. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidme. BMJ 1988; 297: 1017-21.
7. Robinson MG, Griffin JWJ, Bowers J, Kogan FJ, Kogut DG, Lanza FL, et al. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal anti-inflammatory drugs. Dig Dis Sci 1989; 34: 424-8.
8. Stables R, Campbell CJ, Clayton NM, Clitherow JW, Grinham CJ, McColm AA, et al. Gastric anti-secretory, mucosal protective, anti-pepsin, and anti-helicobacter properties of ranitidine bismuth citrate. Aliment Pharmacol Ther 1993; 7: 237-46.
9. Hudson N, Murray FE, Cole AT, Tumbull GM, Lettis GM, Hawkey CJ. Ranitidine bismuth citrate and aspirin-induced gastric mucosal injury. Aliment Pharmacol Ther 1993; 7: 515-21.
10. Djahanguiri B. The production of acute gastric ulceration by indomethacin in the rat. Scand J Gastroenterol 1969; 4: 265-7.
11. Satoh H, Guth PH, Grossman MI. Role of food in gastrointestinal ulceration produced by indomethacin in the rat. Gastroenterology 1982; 83: 210-5.
12. Itoh M, Paulsen G, Guth PH. Hemorrhagic shock and acid gastric injury in the rat. Gastroenterology 1986; 90: 1103-10.
13. Kaneko K, Guth PH, Kaunitz JD. In vivo measurement of rat gastric surface cell intracellular pH. Am J Physiol 1991; 261: G548-52.
14. Kaunitz JD, Nishizaki Y, Kaneko K, Guth PH. Effect of orogastric nicotine on rat gastric mucosal gel thickness, surface cell viability, and intracellular pH. J Pharmacol Exp Ther 1993; 265: 948-54.
15. Nishizaki Y, Guth PH, Kaunitz JD. Isoproterenol enhances rat gastric mucosal barrier function in vivo. Gastroenterology 1993; 105: 340-6.
16. 2 enhances gastric defense mechanisms against acid injury in uremic rats. Gastroenterology 1994; 107: 1382-9.
17. Tanaka S, Kaunitz JD. Indomethacin does not alter the effect of pentagastrin on rat gastric defense mechanisms. Peptides 1996; 17: 155-9.
18. Garner A, Heylings JR. Stimulation of alkaline secretion in amphibian-isolated gastric mucosa by 16,16-dimethyl PGE2 and PGF2a. Gastroenterology 1979; 76: 497-503.
19. Kerss S, Allen A, Garner A. A simple method for measuring thickness of the mucus gel layer adherent to rat, frog, and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents. Clin Sci 1982; 63: 187-95.
20. Slikkcrveer A, Helmich RB, de Wolff FA. Analysis for bismuth in tissue by electrothermal atomic absorption spectrometry. Clin Chem 1993; 39: 800-3.
21. Muǹoz DJB, Tasman-Jones C, Pybus J. Effect of Helicobacter pylori on colloidal bismuth subcitrate concentration in gastric mucus. Gut 1994; 33: 592-6.
22. Nishizaki Y, Guth PH, Kim G, Wayland H, Kaunitz JD. Pentagastrin enhances gastric mucosal defenses in vivo: luminal acid-dependent and independent effects. Am J Physiol 1994; 267: G94-104.
23. Goldenberg MM, Honkomp LJ, Castellion AW. Prevention of bismuth subsalicylate of gastric mucosal lesions in response to noxious stimuli in rats. Pharmacol Res Comm 1978; 10: 13-20.
24. Slomiany BL, Nishikawa H, Bilski J, Slomiany A. Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro. Am J Gastroenterol 1990; 85: 390-3.
25. Koo J, Ho J, Lam SK, Wong J, Ong GB. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat. Gastroenterology 1982; 82: 864-70.
26. Konturek SJ, Bilski J, Kwiecien N, Obtulowicz W, Kopp B, Oleksy J. De-Nol stimulates gastric and duodenal alkaline secretion through prostaglandin dependent mechanism. Gut 1987; 28: 1557-63.
27. Mertz-Nielsen A, Steenberg P, Neumark T, Bukhave K, Rask-Madsen J. Colloidal bismuth subcitrate causes sustained release of gastric mucosal prostaglandin E2. Aliment Pharmacol Ther 1991; 5: 127-33.
28. Manhart MD. In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts. Rev Infect Dis 1990; 12: S11-5.
29. Lambert JR. Pharmacology of bismuth-containing compounds. Rev Infect Dis 1991; 13 (suppl 8): S691-5
30. Navarova J, Nasalova V. Effect of H2-receptor antagonists on indomethacin-induced lysosomal enzyme release from rat gastric mucosa. Methods Find Exp Clin Pharmacol 1994; 16: 119-24.
31. Torii A, Kameda H, Kawamura T, Onizawa N, Nozawa H, Ariizumi M, et al. Effect of gastric mucus on the uptake of the carcinogen MNNG by gastric mucosal DNA. J Clin Gastroenterol 1990; 12 (suppl 1): S116-24.
32. Slomiany BL, Piotrowski J, Ismail A, Rajiyah G, Tamura S, Bielanski W, et al. Protection against alcohol-induced gastric mucosal injury by nitecapone. Gen Pharmacol 1991; 22: 1055-62.
33. Ohara S, Hotta K. Effects of tasting on mucus glycoprotein biosynthesis in rat stomach. Comp Biochem Physiol 1985; 82B: 207-10.
34. Mersereau WA, Hinchey EJ. Relationship between the gastric myoelectric and mechanical activity in the genesis of ulcers in indomethacin-insulin-treated rats. Dig Dis Sci 1988; 33: 200-8.
35. Ueki S, Takeuchi K, Okabe S. Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats. Dig Dis Sci 1988; 33: 209-16.
36. Gerkens JF, Shand DG, Flexner C, Nies AS, Oates JA, Data JL. Effect of indomethacin and aspirin on gastric blood flow and acid secretion. J Pharmacol Exp Ther 1977; 203: 646-52.
37. Holm L, Jägare A. Role of prostaglandins in regulation of gastric mucosal blood flow and acid secretion. Am J Physiol 1992; 263: G446-51.
38. Kiel JW, Riedel GL, DiResta GR, Shepherd AP. Gastric mucosal blood flow measured by laser-Doppler velocimetry. Am J Physiol 1985; 249: G539-45.
39. Engel E, Guth PH, Nishizaki Y, Kasunitz JD. Bamer function of the gastric mucus gel. Am J Physiol 1995; 269: G994-9.
40. Kaneko K, Guth PH, Kaunitz JD NA+/H+ exchange regulates intracellular pH of rat gastric cells in vivo. Pflugers Arch 1992; 421: 322-8.
41. Seidler U, Carter K, Ito S, Silen W. Effect of CO2 on pHi in rabbit parietal, chief, and surface cells. Am J Physiol 1989; 256: G466-75.
42. Crowther RS, Marriott C, James SL. Cation induced changes in the theological properties of purified mucus glycoproteins. Biorheology 1984; 21: 253-61.
43. Forstner JF, Jabbal I, Findlay BP, Forstner GG. Interaction of mucins with calcium, H ion and albumin. Mod Probl Pediatr 1976; 19: 54-65.
44. Marriot C, Shih CK, Litt M. Changes in the gel properties of tracheal mucus induced by divalent cations. Biorheology 1979; 16: 331-7.
45. Lee SP. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid. Scand J Gastroenterol 1982; 17 (suppl 80): 17-21.
46. Takeuchi K, Ueshima K, Hironaka Y, Fujioka Y, Matsumoto J, Okabe S. Oxygen free radicals and lipid peroxidation in the pathogenesis of gastric mucosal lesions induced by indomethacin in rats. Digestion 1991; 49: 175-84.
47. Takeuchi K, Ueki S, Okabe S. Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 1986; 31: 1114-22.
48. Stein J, Zeuzem S, Uphoff K, Laube H. Effects of prostaglandins and indomethacin on gastric emptying in the rat. Prostaglandins 1994; 47: 31-40.
49. Kohut A, Majzis J. Effect of allopurinol and Superoxide dismutase on indomethacin-induced gastric lesions in the rat. Physiol Res 1993; 42: 273-6.
50. Slomiany A, Mizuta K, Piotrowski J, Nishikawa H, Slomiany BL. Gastric mucosal; protection by sucralfate involves phosphoinositides participation. Int J Biochem 1995; 22: 1179-83.
51. Goddard PJ, Kao Y-CJ, Lichtenberger L. Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel. Gastroenterology 1990; 98: 361-70.
52. Kao Y-C, Goddard PJ, Lichtenberger LM. Morphological effects of aspirin and prostaglandin on the canine gastric mucosal surface. Gastroenterology 1990; 98: 592-606.
53. McNulty CAM, Dent J, Wise R. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother 1985; 28: 837-8.
54. Rauws EAJ, Tytgat GN. Campylobacter pylori: treatment of gastritis. In: Rathbone BJ, Heatley RV, ed. Campylobacter pylori and gastrointestinal disease. Oxford: Blackwell Scientific, 1989: 225-32.
55. Coghlan JG, Tobin A, O'Morian C. Campylobacter pylori and ulcer treatment. In: Rathbone BJ, Heatley RV, ed. Campylobacter pylori and gastroduodenal disease. Oxford: Blackwell Scientific, 1989: 232-45.